VALIANT LABORATORIES
|
The Current P/E Ratio of VALIANT LABORATORIES is -43.53.
Share Price | ₹100.0 | Feb 04,2025 |
Market Cap | ₹435.0 Cr | |
Earnings-TTM | ₹-10.0 Cr | TTM-Consolidated Results |
Price/Earnings | -43.53x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of VALIANT LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹435.0 Cr] as on Feb 04,2025
(/) Earnings [ ₹-10.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ -43.53x ]
Thus, for VALIANT LABORATORIES , the investors are currently willing to pay -43.53 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of VALIANT LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of VALIANT LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of VALIANT LABORATORIES
PE Ratio Performance Analysis for VALIANT LABORATORIES
- VALIANT LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2023 averaged 989.13x.
- VALIANT LABORATORIES 's operated at median p/e ratio of 1978.26x from fiscal years ending March 2018 to 2022.
- Looking back at the last 2 fiscal years, VALIANT LABORATORIES 's p/e ratio peaked in Mar2024 at 1978.26x.
- VALIANT LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does VALIANT LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
VALIANT LABORATORIES | -9.99 | -43.53 | 435.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 36.91 | 423,974.0 |
CIPLA LTD | 5,000.43 | 23.40 | 116,999.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 18.75 | 101,771.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 22.79 | 97,951.9 |
DIVIS LABORATORIES LTD | 2,067.00 | 78.24 | 161,729.0 |
MANKIND PHARMA LTD | 2,050.73 | 51.33 | 105,258.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 56.44 | 105,089.0 |
LUPIN LTD | 2,651.94 | 36.33 | 96,354.0 |
AUROBINDO PHARMA LTD | 3,598.83 | 18.90 | 68,023.5 |
ABBOTT INDIA LTD | 1,284.66 | 43.24 | 55,551.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs VALIANT LABORATORIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | -43.53x |
Max industry PE | 78.24x |
Median industry PE | 36.33x |
Average industry PE | 31.16x |
You may also like the below Video Courses